ETHOX INTERNATIONAL, INC. – Trademark Portfolio
Entity Type: 03
ETHOX INTERNATIONAL, INC. holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 11 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include ETHOX, LAP-KIT, COMBIPORT, INFU-SURG, and SURGI-KIT. The owner is based in BUFFALO, NY.
251 SENECA STREET
BUFFALO, NY 14204
Showing of trademarks Trademarks
Trademark Classifications
ETHOX INTERNATIONAL, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does ETHOX INTERNATIONAL, INC. have?
ETHOX INTERNATIONAL, INC. has 13 U.S. trademarks filed with the USPTO. Of these, 7 registered, 6 cancelled.
What trademark classes does ETHOX INTERNATIONAL, INC. file in?
ETHOX INTERNATIONAL, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 40 (Treatment & Processing). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are ETHOX INTERNATIONAL, INC.'s most well-known trademarks?
ETHOX INTERNATIONAL, INC.'s registered trademark portfolio includes well-known marks such as ETHOX, LAP-KIT, COMBIPORT, INFU-SURG, and SURGI-KIT. These are among 7 currently registered trademarks in the portfolio.
What is ETHOX INTERNATIONAL, INC.'s trademark registration success rate?
ETHOX INTERNATIONAL, INC. has a 54% trademark registration rate, with 7 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.